- Home
- DUOT vs SNSE Comparison
DUOT vs SNSE Comparison
Compare DUOT & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUOT
- SNSE
- Stock Information
- Founded
- DUOT 1990
- SNSE 2005
- Country
- DUOT United States
- SNSE United States
- Employees
- DUOT N/A
- SNSE N/A
- Industry
- DUOT Computer Software: Prepackaged Software
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- DUOT Technology
- SNSE Health Care
- Exchange
- DUOT Nasdaq
- SNSE Nasdaq
- Market Cap
- DUOT 24.2M
- SNSE 11.7M
- IPO Year
- DUOT N/A
- SNSE 2021
- Fundamental
- Price
- DUOT $3.83
- SNSE $0.42
- Analyst Decision
- DUOT Strong Buy
- SNSE Strong Buy
- Analyst Count
- DUOT 1
- SNSE 3
- Target Price
- DUOT $6.00
- SNSE $4.33
- AVG Volume (30 Days)
- DUOT 55.9K
- SNSE 71.5K
- Earning Date
- DUOT 11-12-2024
- SNSE 11-05-2024
- Dividend Yield
- DUOT N/A
- SNSE N/A
- EPS Growth
- DUOT N/A
- SNSE N/A
- EPS
- DUOT N/A
- SNSE N/A
- Revenue
- DUOT $5,638,027.00
- SNSE N/A
- Revenue This Year
- DUOT $66.43
- SNSE N/A
- Revenue Next Year
- DUOT $83.75
- SNSE N/A
- P/E Ratio
- DUOT N/A
- SNSE N/A
- Revenue Growth
- DUOT N/A
- SNSE N/A
- 52 Week Low
- DUOT $1.94
- SNSE $0.38
- 52 Week High
- DUOT $5.74
- SNSE $1.94
- Technical
- Relative Strength Index (RSI)
- DUOT 67.66
- SNSE 37.16
- Support Level
- DUOT $3.05
- SNSE $0.43
- Resistance Level
- DUOT $4.34
- SNSE $0.52
- Average True Range (ATR)
- DUOT 0.33
- SNSE 0.05
- MACD
- DUOT 0.09
- SNSE -0.00
- Stochastic Oscillator
- DUOT 67.10
- SNSE 0.00
About DUOT Duos Technologies Group Inc.
Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.